Turning stats into outcomes
June 18, 2012
New applications in drug discovery platforms are set to fuel advances in stem cell therapies, but a raft of ethical, clinical and commercial issues will need to be navigated in order for the market's full potential can be unleashed, says a new study.
October 20, 2011
The future of the biotech industry in Europe has been cast into doubt after the European Court of Justice banned patents on stem cell work involving the destruction of human embryos.
PharmaTimes 2013 Copyright | RSS Feed Subscriptions